Skip to main content
. 2021 Apr 22;9(5):420. doi: 10.3390/vaccines9050420

Figure 2.

Figure 2

Schematic representation of the T-dependent mechanism of the PCV 13 vaccine. The polysaccharidic portion of PCV stimulates the production of plasma cells, while the carrier portion of PCV activates CD4+ T lymphocytes that induces memory B cell proliferation and long-lived plasma cells.